Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Alexis James, BA 508-847478
alexis.james@interscopemed.com


Jeffery B Ryan Jr, BA 617-360-1168
jeffery.ryan@interscopemed.com


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Endorotor Resection In Refractory Barrett's Dysplasia Patients
Back

Endorotor Resection In Refractory Barrett's Dysplasia Patients

Recruiting

Open to: ALL

Age: 30.0 - 89.0

London Nottingham

Medical Conditions

Barrett Esophagus

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The aim of the clinical trial is to evaluate the EndoRotor®'s ability to completely remove areas of Barrett's esophagus considered refractory after 3 failed ablation treatments (Radiofrequency Ablation (RFA) and/or Cryotherapy) or in patients with at least 1 failed ablative procedure (RFA and/or Cryotherapy) and are intolerant to the procedure due to pain, where intolerant is defined as post-dysphagia or odynophagia persisting for 24 hours or greater or requiring narcotic analgesia for a duration of more than 24 hours.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Feb 2018 Dec 2024

INTERVENTIONAL

Intervention Type : DEVICE
Intervention Description : The EndoRotor® Endoscopic Mucosal Resection System is an automated mechanical endoscopic mucosal resection system for use in the gastrointestinal tract for benign neoplastic or pre-malignant tissue removal by interventional gastroenterologists and GI surgeons. The EndoRotor® System performs both tissue dissection and resection with a single device through an endoscope's instrument biopsy channel.

Intervention Arm Group : EndoRotor Resection;

Intervention Type : DEVICE
Intervention Description : Continued ablation control shall include either cryotherapy or continued radial frequency ablation.

Intervention Arm Group : Continued Ablation (Control);



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • NHS University College Hospital
    London
  • Nottingham University Hospitals NHS Trust and University of Nottingham
    Nottingham
    NG7 2UH

Jeffery B Ryan Jr, BA 617-360-1168
jeffery.ryan@interscopemed.com


Alexis James, BA 508-847478
alexis.james@interscopemed.com



The study is sponsored by Interscope, Inc.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT03364114
Last updated 01 August 2022

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top